Mechanistic investigation into the phase separation behavior of soluplus in the presence of biorelevant media
dc.contributor.author | Lange, Justus Johann | en |
dc.contributor.author | Senniksen, Malte Bøgh | en |
dc.contributor.author | Wyttenbach, Nicole | en |
dc.contributor.author | Page, Susanne | en |
dc.contributor.author | Bateman, Lorraine M. | en |
dc.contributor.author | O’Dwyer, Patrick J. | en |
dc.contributor.author | Saal, Wiebke | en |
dc.contributor.author | Kuentz, Martin | en |
dc.contributor.author | Griffin, Brendan T. | en |
dc.contributor.funder | Horizon 2020 | en |
dc.date.accessioned | 2025-03-26T12:13:54Z | |
dc.date.available | 2025-03-26T12:13:54Z | |
dc.date.issued | 2025 | en |
dc.description.abstract | More than a decade since its introduction, the polymeric excipient Soluplus continues to receive considerable attention for its application in the development of amorphous solid dispersions (ASDs) and its utility as a solubilizer for drugs exhibiting solubility limited absorption. While it is well-recognized that Soluplus forms micelles, the impact of its lower critical solution temperature of approximately 40 °C remains an underexplored aspect. This study investigated the phase behavior of Soluplus in fasted-state simulated intestinal fluid (FaSSIF-V1). It was demonstrated that Soluplus forms a dispersed polymer-rich coacervate phase, which coexists with Soluplus micelles at 37 °C. This behavior was confirmed by cloud point measurements, visually discernible phases after centrifugation, as well as multi-angle dynamic light scattering (MADLS) measurements, and quantitative 1H-nuclear magnetic resonance (NMR) spectroscopy of Soluplus concentrations in the supernatant pre- and post-centrifugation. The practical relevance of these findings was contextualized by solvent shift experiments and dissolution testing of spray-dried ASD. The results demonstrated that the poorly water-soluble drug RO6897779 resided in a polymer-rich coacervate phase and was spun down during centrifugation, which resulted in an amorphous pellet exhibiting the characteristics of a viscous liquid. The entrapment of the drug within the polymer-rich phase was further analyzed by temperature- and time-dependent MADLS experiments. The findings of this study are of particular relevance for a mechanistic understanding, relevant to comprehending in vitro-in vivo relationships of Soluplus-based ASDs. Low sampled drug concentrations in FaSSIF-V1 at 37 °C may originate not only from limited drug release and precipitation but also from the formation of a drug-containing, polymer-rich Soluplus phase. Therefore, a liquid–liquid phase separation occurring from Soluplus-based formulations in a biorelevant medium can be excipient-driven, which is different from the common perception that phase separation in the solution state is triggered primarily by high drug concentrations exceeding their amorphous solubility. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Lange, J.J., Senniksen, M.B., Wyttenbach, N., Page, S., Bateman, L.M., O’Dwyer, P.J., Saal, W., Kuentz, M. and Griffin, B.T. (2025) ‘Mechanistic investigation into the phase separation behavior of soluplus in the presence of biorelevant media’, Molecular Pharmaceutics, p. acs.molpharmaceut.4c01140 (15pp). https://doi.org/10.1021/acs.molpharmaceut.4c01140 | en |
dc.identifier.doi | 10.1021/acs.molpharmaceut.4c01140 | en |
dc.identifier.eissn | 1543-8392 | en |
dc.identifier.endpage | 15 | en |
dc.identifier.issn | 1543-8384 | en |
dc.identifier.journaltitle | Molecular Pharmaceutics | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/17198 | |
dc.language.iso | en | en |
dc.publisher | ACS American Chemical Society | en |
dc.relation.project | 955756 | en |
dc.rights | © 2025, the Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Soluplus | en |
dc.subject | Phase separation | en |
dc.subject | Amorphous solid dispersions | en |
dc.subject | Supersaturation | en |
dc.subject | Bioenabling formulations | en |
dc.subject | Solubility | en |
dc.subject | Liquid−liquid phase separation | en |
dc.subject | Formulation | en |
dc.title | Mechanistic investigation into the phase separation behavior of soluplus in the presence of biorelevant media | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- lange-et-al-2025-mechanistic-investigation-into-the-phase-separation-behavior-of-soluplus-in-the-presence-of.pdf
- Size:
- 6.32 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
Loading...
- Name:
- mp4c01140_si_001.pdf
- Size:
- 6.22 MB
- Format:
- Adobe Portable Document Format
- Description:
- Supporting Information
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: